Mole mapping: who needs it, how often, and what the appointment involves

The short version

Mole mapping is a non-invasive way of detecting change in pigmented lesions over time. A specialist system photographs the whole skin surface, captures close-up dermoscopic images of lesions of concern, and stores them so they can be compared at the next visit. It is most useful for people with a lot of moles, atypical moles, a personal or family history of melanoma, fair sun-damaged skin, or a suppressed immune system. For those groups, annual review is a sensible baseline, with some profiles reviewed more often. For everyone else, a good skin self-check and a sensible relationship with the sun will usually do more.

Melanoma cases in the UK are now at a record high. Cancer Research UK reports more than 20,000 melanoma diagnoses in 2022, projected to reach 26,500 a year by 2040, with nearly nine in ten cases linked to UV exposure from the sun and sunbeds. That is the backdrop to any conversation about screening, and it is the reason we offer mapping at the clinic for the people most likely to benefit from it.

What mole mapping actually is

Digital mole mapping uses a photo documentation system to record the moles on your body. Whole-body images map the position of every lesion. Close-up dermoscopic images can be taken of any mole of concern, capturing structure, pigment network and borders at a level the naked eye cannot see. At your next appointment, the new images are compared with the originals, and any change in size, shape, colour or new lesion appearance can be flagged. Many modern systems use AI to assist that comparison, but the clinical decision still sits with the practitioner.

The point of mapping is not to diagnose a single mole in isolation. The point is change over time. A still photograph today is not very interesting on its own. A still photograph today, set against the same view six or twelve months from now, can reveal subtle evolution that would otherwise be missed, including the appearance of new lesions in adults, which is one of the more meaningful warning signs.

Who genuinely benefits

The NHS does not offer routine mole mapping to the general public. Dermatology surveillance is typically reserved for patients with a history of dysplastic naevus syndrome or previous melanoma, and primary care is asked to manage stable, benign-looking moles without imaging. That is not because mapping is useless, but because the evidence for benefit concentrates in higher-risk groups. A 2025 evaluation in the British Journal of Dermatology described referral criteria along the lines of three of: a history of melanoma, around 100 or more common moles, at least five atypical moles, or at least two larger acquired moles greater than 8mm.

Research published through PubMed Central found that screening and digital mole mapping showed no significant benefit in low-risk patients, but in high-risk patients tumour thickness at diagnosis decreased. Thinner tumours at diagnosis mean better outcomes. That study supports a risk-adapted approach, with intensified, digitally supported follow-up for those most likely to develop a melanoma.

In practical terms, the people I would actively recommend consider mapping are:

• · Anyone with a large number of moles overall, particularly around 50 or more.
• · Anyone with atypical or irregular moles, especially those larger than 5mm with uneven colour or borders.
• · A personal history of melanoma or non-melanoma skin cancer.
• · A first-degree family history of melanoma.
• · Fair skin, freckling or red hair (skin types I and II) combined with significant lifetime sun exposure or sunbed use.
• · Immunosuppression, including transplant recipients and those living with HIV.

If none of those apply to you, mapping is not wrong, but a careful monthly self-check using the ABCDE method will usually serve you well. If you have not come across it, our guide on when to worry about a mole walks through what to look for at home.

How often you should be mapped

For most higher-risk adults, annual mapping is the sensible baseline. NHS dermatology leaflets describe a range of three months to yearly depending on individual risk, with the frequency decided clinically. If a particular mole is being watched closely, a short-interval review at three to six months can be useful, after which the cadence can stretch back out if everything is stable. If nothing of concern is found and the risk profile is low, repeat imaging may not be needed at all.

In my clinic, six-monthly review tends to be reserved for patients with a personal history of melanoma, atypical mole syndrome, or active immunosuppression. Annual review is the standard for everyone else who meets the high-risk criteria. The honest answer at the end of your first appointment will depend on what we find, not on a pre-decided schedule.

What the appointment looks like

NHS patient leaflets put a typical mole mapping appointment at around 30 to 40 minutes, and that is broadly what to expect with us. The visit has three parts: preparation, photography and dermoscopic review.

Preparation is simple but matters. The skin needs to be uncovered so that as many moles as possible can be captured. Please come with no make-up, no fake tan, and ideally no jewellery. Long hair will be tied back. You will be asked to undress to your underwear and to wear similar underwear to any future appointments so that the same areas of skin can be compared like-for-like. Before any images are taken, a consent form is signed for taking and storing medical images.

The photography itself is a sequence of standardised poses, capturing the whole skin surface in defined views. Close-up dermoscopic images are then taken of any moles that look worth a second look, or that you have specifically asked about. Nothing is cut, injected or removed. There is no downtime. You can dress and leave straight after.

The report that follows is the clinical product of the visit. It will describe what was seen, flag anything that needs a closer look, and recommend when, if at all, to return. If something genuinely concerning is found, the next step is referral for assessment and, where indicated, excision and histology. Mapping is a screening and surveillance tool. It is not a substitute for biopsy when a lesion warrants one.

A short honesty note on private skin screening

Private mole checks in Essex and elsewhere vary widely in quality. Some are a five-minute eyeball under a hand lens. Some are a full photographic baseline with structured dermoscopy. Both can be advertised as a "mole check" and that is unhelpful for the public. When you book, ask what is included, who is reviewing the images, what their training is, and what happens if something is found. Our clinical standards and registration details are on our qualifications page if you want to read them before you book.

The wider context is also worth mentioning. The UK aesthetics sector remains largely unregulated at the practitioner level, the proposed licensing scheme for England is not yet in force, and a further consultation is expected before legislation. Skin screening sits on the medical side of what we do, and we run it to medical standards regardless of where licensing eventually lands. If you want the broader picture, our overview of what is changing in 2026 covers it.